Citadel Advisors
YDES

Citadel Advisors’s YD Bio Ltd YDES Stock Holding History

Citadel Advisors’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7K Buy
30,106
+10,656
+55% +$47.6K ﹤0.01% 12956
2026
Q1 		$150K Buy
19,450
+7,901
+68% +$76.3K ﹤0.01% 11682
2025
Q4 		$141K Buy
+11,549
New +$156K ﹤0.01% 11370

Other funds holding YDES

GWAG
Garrett Wealth Advisory Group Weatherford, Texas $651M AUM 23.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors's YDES Position: Q2 2026 in Review

Citadel Advisors increased its YD Bio Ltd (YDES) stake by 55% in Q2 2026, buying an estimated $47.6K and bringing the position to 30,106 shares worth $67.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12956.

Citadel Advisors first reported a position in YDES in Q4 2025 and has held it in 3 quarters since. The position peaked at $150K in Q1 2026. 12 funds tracked by Wall St. Rank hold YDES as of Q2 2026.

  • Citadel Advisors held 30,106 shares of YD Bio Ltd worth $67.7K as of Q2 2026.
  • Citadel Advisors bought 10,656 YD Bio Ltd shares in Q2 2026, an estimated $47.6K.
  • YD Bio Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12956 holding.
  • Citadel Advisors first reported a position in YD Bio Ltd in Q4 2025 and has held it in 3 quarters since.
  • Citadel Advisors's YD Bio Ltd position peaked at $150K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held YD Bio Ltd as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.